Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of N-Acetyl-GED-0507-34-Levo 5% gel versus vehicle in acne vulgaris
ISRCTN18067422Phase 3Completed
- Sponsor
- PPM Services
- Start
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in acne vulgaris comparing N-Acetyl-GED-0507-34-Levo 5% gel with Vehicle gel (2 arms). Primary endpoints: Relative change in total facial lesion count at Week 12 and Change in facial acne severity by IGA at Week 12. Started Nov 2024; status: completed.
02
Drugs
N-acetyl-GED-0507-34-LEVO
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on ISRCTN18067422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18067422.